Title: 2025-2026 Regular Session HB 446 PN 2439 Bill Text (HTM)
Official Title: 
Number of Sections: 1
Source: versions - Printer's No. PN2439
Media Type: text/html

================================================================================

Section 1:
2025-2026 Regular Session HB 446 PN 2439 Bill Text (HTM) See other bills under thesame topic PRIOR PRINTER'S NOS. 424, 2021PRINTER'S NO. 2439THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE BILL No.446 Session of 2025 INTRODUCED BY SANCHEZ, KHAN, GUENST, GIRAL, PIELLI, HOWARD, DONAHUE, HADDOCK, HILL-EVANS, FREEMAN, FLEMING, CIRESI, CERRATO, GREEN, VENKAT, FRANKEL, BURGOS AND SHAFFER, FEBRUARY 3, 2025 AS AMENDED ON SECOND CONSIDERATION, HOUSE OF REPRESENTATIVES, OCTOBER 8, 2025AN ACTAmending the act of July 19, 1979 (P.L.130, No.48), entitled "An act relating to health care; prescribing the powers and duties of the Department of Health; establishing and providing the powers and duties of the State Health Coordinating Council, health systems agencies and Health Care Policy Board in the Department of Health, and State Health Facility Hearing Board in the Department of Justice; providing for certification of need of health care providers and prescribing penalties," in licensing of health care facilities, providing for medication offered to patient.The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows:Section 1. The act of July 19, 1979 (P.L.130, No.48), known as the Health Care Facilities Act, is amended by adding a section to read:Section 809.3. Medication offered to patient.(a) General rule.--For a facility-provided medication administered to a patient during an episode of care in a hospital or ambulatory surgical facility, any unused portion of the medication billed to the patient or that would otherwise be 1234567891011121314151617181920 discarded after partial use during the episode of care shall be offered to the patient at no additional charge upon discharge if:(1) offering the medication to the patient meets the prescriber's standard of care; and(2) the prescriber determines that the facility-provided medication is required for continuing treatment.(b) Duties when dispensing medication.--Notwithstanding any other provision of law, when a facility-provided medication is dispensed in accordance with subsection (a), the following apply:(1) A facility-provided medication that contains a label with the same information used during institutional administration as required under 49 Pa. Code ยง 27.18(v) (relating to standards of practice) shall fulfill the labeling requirements under the act of September 27, 1961 (P.L.1700, No.699), known as the "Pharmacy Act," the act of April 14, 1972 (P.L.233, No.64), known as "The Controlled Substance, Drug, Device and Cosmetic Act," or regulations promulgated by the State Board of Pharmacy.(2) A prescriber may fulfill the pharmacist counseling requirements under 49 Pa. Code ยง 27.19(d) or (e) (relating to prospective drug review and patient counseling) by offering to counsel or by counseling a patient or caregiver in accordance with the regulation.(3) A hospital or ambulatory surgical facility shall include, in any discharge instructions, the following:(i) Written instructions for the facility-provided medication's proper use and administration, including the remaining number of doses to the extent quantifiable or 20250HB0446PN2439 - 2 - 123456789101112131415161718192021222324252627282930 calculable.(ii) A phone number to contact CONTACT INFORMATION FOR the prescriber or pharmacist. (c) Exemption from outpatient dispensing requirements.--A facility-provided medication that is offered or dispensed in accordance with this section shall not be considered outpatient dispensing under the "Pharmacy Act," "The Controlled Substance, Drug, Device and Cosmetic Act" or regulations promulgated by the State Board of Pharmacy.(d) Liability protection.--A prescriber, pharmacist, hospital or ambulatory surgical facility acting in good faith and in accordance with this section shall not be held civilly or administratively liable for any injury or harm resulting from a patient's misuse, nonadherence or failure to follow discharge instructions related to a facility-provided medication, unless the injury or harm results from gross negligence or willful misconduct.(e) Definitions.--As used in this section, the following words and phrases shall have the meanings given to them in this subsection unless the context clearly indicates otherwise:"Facility-provided medication." A multi-use MULTI-DOSE drug product intended for a single patient that is clinically appropriate for the acute A CLINICAL condition causing REQUIRING TREATMENT DURING the hospital or ambulatory surgical facility episode of care and APPROPRIATE for continued use post- discharge, such as eye drops, ear drops, a topical cream or an emergency inhaler. The term does not include a product that is used intravenously or is a DRUG CLASSIFIED AS A controlled substance UNDER THE CONTROLLED SUBSTANCE, DRUG, DEVICE AND COSMETIC ACT . 20250HB0446PN2439 - 3 - <--<--<--<--<--<--<--<--<--123456789101112131415161718192021222324252627282930 "Prescriber." A person that is licensed, registered or otherwise authorized to distribute, dispense and administer a controlled substance, other drug or device in the course of professional practice or research in this Commonwealth. The term does not include a veterinarian.Section 2. This act shall take effect in 60 days.20250HB0446PN2439 - 4 - 123456


================================================================================

Raw Text:
2025-2026 Regular Session HB 446 PN 2439 Bill Text (HTM) See other bills under thesame topic PRIOR PRINTER'S NOS. 424, 2021PRINTER'S NO. 2439THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE BILL No.446 Session of 2025 INTRODUCED BY SANCHEZ, KHAN, GUENST, GIRAL, PIELLI, HOWARD, DONAHUE, HADDOCK, HILL-EVANS, FREEMAN, FLEMING, CIRESI, CERRATO, GREEN, VENKAT, FRANKEL, BURGOS AND SHAFFER, FEBRUARY 3, 2025 AS AMENDED ON SECOND CONSIDERATION, HOUSE OF REPRESENTATIVES, OCTOBER 8, 2025AN ACTAmending the act of July 19, 1979 (P.L.130, No.48), entitled "An act relating to health care; prescribing the powers and duties of the Department of Health; establishing and providing the powers and duties of the State Health Coordinating Council, health systems agencies and Health Care Policy Board in the Department of Health, and State Health Facility Hearing Board in the Department of Justice; providing for certification of need of health care providers and prescribing penalties," in licensing of health care facilities, providing for medication offered to patient.The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows:Section 1. The act of July 19, 1979 (P.L.130, No.48), known as the Health Care Facilities Act, is amended by adding a section to read:Section 809.3. Medication offered to patient.(a) General rule.--For a facility-provided medication administered to a patient during an episode of care in a hospital or ambulatory surgical facility, any unused portion of the medication billed to the patient or that would otherwise be 1234567891011121314151617181920 discarded after partial use during the episode of care shall be offered to the patient at no additional charge upon discharge if:(1) offering the medication to the patient meets the prescriber's standard of care; and(2) the prescriber determines that the facility-provided medication is required for continuing treatment.(b) Duties when dispensing medication.--Notwithstanding any other provision of law, when a facility-provided medication is dispensed in accordance with subsection (a), the following apply:(1) A facility-provided medication that contains a label with the same information used during institutional administration as required under 49 Pa. Code ยง 27.18(v) (relating to standards of practice) shall fulfill the labeling requirements under the act of September 27, 1961 (P.L.1700, No.699), known as the "Pharmacy Act," the act of April 14, 1972 (P.L.233, No.64), known as "The Controlled Substance, Drug, Device and Cosmetic Act," or regulations promulgated by the State Board of Pharmacy.(2) A prescriber may fulfill the pharmacist counseling requirements under 49 Pa. Code ยง 27.19(d) or (e) (relating to prospective drug review and patient counseling) by offering to counsel or by counseling a patient or caregiver in accordance with the regulation.(3) A hospital or ambulatory surgical facility shall include, in any discharge instructions, the following:(i) Written instructions for the facility-provided medication's proper use and administration, including the remaining number of doses to the extent quantifiable or 20250HB0446PN2439 - 2 - 123456789101112131415161718192021222324252627282930 calculable.(ii) A phone number to contact CONTACT INFORMATION FOR the prescriber or pharmacist. (c) Exemption from outpatient dispensing requirements.--A facility-provided medication that is offered or dispensed in accordance with this section shall not be considered outpatient dispensing under the "Pharmacy Act," "The Controlled Substance, Drug, Device and Cosmetic Act" or regulations promulgated by the State Board of Pharmacy.(d) Liability protection.--A prescriber, pharmacist, hospital or ambulatory surgical facility acting in good faith and in accordance with this section shall not be held civilly or administratively liable for any injury or harm resulting from a patient's misuse, nonadherence or failure to follow discharge instructions related to a facility-provided medication, unless the injury or harm results from gross negligence or willful misconduct.(e) Definitions.--As used in this section, the following words and phrases shall have the meanings given to them in this subsection unless the context clearly indicates otherwise:"Facility-provided medication." A multi-use MULTI-DOSE drug product intended for a single patient that is clinically appropriate for the acute A CLINICAL condition causing REQUIRING TREATMENT DURING the hospital or ambulatory surgical facility episode of care and APPROPRIATE for continued use post- discharge, such as eye drops, ear drops, a topical cream or an emergency inhaler. The term does not include a product that is used intravenously or is a DRUG CLASSIFIED AS A controlled substance UNDER THE CONTROLLED SUBSTANCE, DRUG, DEVICE AND COSMETIC ACT . 20250HB0446PN2439 - 3 - <--<--<--<--<--<--<--<--<--123456789101112131415161718192021222324252627282930 "Prescriber." A person that is licensed, registered or otherwise authorized to distribute, dispense and administer a controlled substance, other drug or device in the course of professional practice or research in this Commonwealth. The term does not include a veterinarian.Section 2. This act shall take effect in 60 days.20250HB0446PN2439 - 4 - 123456